The upcoming K-drama Hyper Knife’s cast has been confirmed. The Castaway Diva actress Park Eun-Bin is going to be featured as the lead. Apart from her, Park Byung-Eun, Sol Kyung-Gu, and Yoon Cha-Young have also been confirmed. Crazy Love director Kim Jung-Hyun is helming the drama. On the other hand, the writer of the webtoon Bangjungsa, Kim Seon-Hee is writing it.
Hyper Knife (literal translation) is a medical thriller K-drama. The storyline delves into the lives of Doctor Jung Se-Ok (Eun-Bin) and her mentor, Deok Hee (Sol Kyung Gu). The narrative depicts what happens when two geniuses reunite after a long time. As per the story, Se-Ok’s mentor caused her to hit rock bottom even after having a promising past.
Upcoming K-drama Hyper Knife cast and character details: Park Eun-Bin, Sol Kyung-Gu, and more
The medical thriller drama Hyper Knife promises to portray different layers of storylines. Sol Kyung-Gu will play a star neurosurgeon’s character, Deok Hee. He will mentor Se-Ok and be the reason behind her career hitting rock bottom.
In a certain turn of events, Deok Hee kicks out his student, Se-Ok, from the operating room, leaving her in distress. On the other hand, Se-Ok, who once had an illustrious career as a genius doctor, now lives as a shadow doctor. Se-Ok (Park Eun-Bin) now stays in illegal operation rooms.
Park Byung-Eun plays anesthesiologist Han Hyun-Ho in the drama Hyper Knife. He believes in Se-Ok’s skills and wants the world to see her capability. On the other hand, the drama will also feature Yoon Chan-Young. He will portray Seo Young-Joo, a character who always sides with Se-Ok (Park Eun-Bin) and protects her from anything like a shadow.
After Extraordinary Attorney Woo and Castaway Diva, Park Eun-Bin is all set to get under the skin of another character. She has been proving her versatility with each project, and her fans are going gaga about it. The viewers can’t wait to get more information about the drama Hyper Knife.
Park Eun-Bin’s Hyper Knife has gone into filming, and more updates are on its way. Stay tuned for more updates.
